CD274 and neoplasm: Thus, it appears that the PD-1/PD-L1 axis increases the glycolysis in tumor cells to support their proliferation, drug resistance, and invasion while suppressing the immune cells' ability to metabolize glucose, thereby weakening their anti-tumor effectiveness.